Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 12 recruiting now full pipeline

Cigarette Smoking-Related Carcinoma: full-pipeline trial registry

12 of 22 indexed Cigarette Smoking-Related Carcinoma trials are currently recruiting.

Corpus placement: #756 of 28,707 conditions by registered trial count.

22 US clinical trials · 12 currently recruiting · #756 of 28,707 conditions by registered trial count

Cigarette Smoking-Related Carcinoma: 22 US clinical trials tracked, 12 recruiting.

Cigarette Smoking-Related Carcinoma is the subject of 22 registered US clinical trials on ClinicalTrials.gov, 12 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Ohio State University Comprehensive Cancer Center, running 6 of these trials.

Enrollment posture brief

Registry condition cigarette-smoking-related-carcinoma

OPEN 12 | RECR 55% | LATE 3 | EARLY 4 | RANK #756 | SPON 6

Nearest open-share peer: Advanced Ovarian Carcinoma (55% recruiting · 11 trials)

Advanced Melanoma63.6%Cigarette Smoking-Relate (th…55%Acute Myeloid Leukemia Arisi18.2%Adenocarcinoma of the Prosta0%Adult Acute Myeloid Leukemia0%
Open-enrollment share among volume-matched conditions near Cigarette Smoking-Related Carcinoma

Cigarette Smoking-Related Carcinoma lists 12 open slots (55% of 22 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cigarette Smoking-Related Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cigarette Smoking-Related Carcinoma is recruiting above its size-band peers.

    12 of 22 indexed trials (54.5%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cigarette Smoking-Related Carcinoma research.

    Ohio State University Comprehensive Cancer Center accounts for 6 of 22 trials (27.3%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Cigarette Smoking-Related Carcinoma enrolment sits around 182 participants.

    Median target enrolment is 182 among the 22 trials that report a genuine target (sentinel values excluded). 6 of those (27.3%) plan for fewer than 100 participants.

  4. Cigarette Smoking-Related Carcinoma research is mostly interventional.

    18 interventional and 4 observational studies make up this index (81.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 22Phase 32Phase 41

Open and recent trials

22 total, page 1 of 1

RECRUITING Phase 4 2,010 participants

Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial

M.D. Anderson Cancer Center

NCT04604509

RECRUITING NA 1,500 participants

A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior

Ohio State University Comprehensive Cancer Center

NCT06260683

RECRUITING NA 1,000 participants

Oral Nicotine Pouches Versus Nicotine Replacement Therapy to Reduce Cigarette Use for Smokers in Rural Appalachia

Ohio State University Comprehensive Cancer Center

NCT06763536

RECRUITING NA 776 participants

A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial

Fred Hutchinson Cancer Center

NCT06145763

RECRUITING Phase 3 600 participants

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Alliance for Clinical Trials in Oncology

NCT05008848

RECRUITING NA 298 participants

Smoking Cessation Intervention Development for Homeless Youth

Ohio State University Comprehensive Cancer Center

NCT06754215

RECRUITING 150 participants

Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study)

Roswell Park Cancer Institute

NCT07167225

RECRUITING NA 147 participants

CONNECTing to LungCare

University of California, San Francisco

NCT06213532

RECRUITING Phase 2 135 participants

Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers

National Cancer Institute (NCI)

NCT05121051

RECRUITING 40 participants

Understanding Tobacco and Cannabis Co-Use Practices: Initiation, Escalation, and Maintenance

Roswell Park Cancer Institute

NCT07439471

RECRUITING Early Phase 1 30 participants

Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults

Roswell Park Cancer Institute

NCT06816459

RECRUITING NA 30 participants

Studying Flavors and Cooling Agents in Oral Nicotine Pouches to Understand User Preferences

Ohio State University Comprehensive Cancer Center

NCT07111234

ACTIVE NOT RECRUITING Phase 3 1,647 participants

An Innovative Conversational Agent (Quitbot) for Smoking Cessation

Fred Hutchinson Cancer Center

NCT04308759

ACTIVE NOT RECRUITING NA 191 participants

Increasing Access to Smoking Cessation and Smoke Free Home Services for Low-Income Pregnant Women in Northeast Texas

M.D. Anderson Cancer Center

NCT05051345

ACTIVE NOT RECRUITING 182 participants

Impact of E-cigarette Use on the Body

Ohio State University Comprehensive Cancer Center

NCT04972513

ACTIVE NOT RECRUITING NA 104 participants

Evaluating the Episodic Future Thinking Intervention for Reducing Cigarette Consumption in Cigarette Smokers

Roswell Park Cancer Institute

NCT05825001

ACTIVE NOT RECRUITING Phase 2 41 participants

Evaluation of Canakinumab in High-Risk Former-Smokers

Peter Shields

NCT06038526

COMPLETED NA 500 participants

Pilot Trial of a Game Embedded in a Smartphone App for Smoking Cessation

University of California, San Francisco

NCT05227027

COMPLETED 182 participants

Electronic Cigarette Use During Pregnancy

UConn Health

NCT03480373

COMPLETED NA 169 participants

Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes

M.D. Anderson Cancer Center

NCT03856515

COMPLETED Phase 1 53 participants

Website Smoking Cessation Intervention for the Promotion of Smoking Cessation in Low-Income Veterans

Fred Hutchinson Cancer Center

NCT04502524

COMPLETED NA 27 participants

Evaluating the Impact of Quitting Using Executive Function Strategy Training (QUEST) on Smoking Cessation in Homeless Young Adult Smokers

Ohio State University Comprehensive Cancer Center

NCT06745154

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 2
Phase 3 2
Phase 4 1

Named interventions

Most-linked intervention names on Cigarette Smoking-Related Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Questionnaire Administration Other
8 trials
Survey Administration Other
6 trials
Smoking Cessation Intervention Behavioral
6 trials
Biospecimen Collection Procedure
5 trials
Nicotine Replacement Drug
4 trials
Carbon Monoxide Measurement Procedure
2 trials
Informational Intervention Other
2 trials
Health Promotion and Education Other
2 trials

US sites by state

Facility locations filed on Cigarette Smoking-Related Carcinoma trials. A trial with sites in several states counts in each.

Ohio 7 trials
New York 5 trials
Texas 3 trials
California 3 trials
Washington 2 trials
Massachusetts 2 trials
Colorado 2 trials
Arizona 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cigarette Smoking-Related Carcinoma page

22 registered trials, 12 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cigarette Smoking-Related Carcinoma condition card totals 22 registered trials; most-linked intervention Questionnaire Administration; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.